$48.85
+1.16 (+2.43%)
At Close: Jun 04, 2026
Boston Scientific Elects David Habiger to Board of Directors
04:05pm, Tuesday, 30'th Jul 2024
MARLBOROUGH, Mass. , July 30, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of David Habiger to its board of directors, effective immediately.
3 Record-Breaking Stocks With More Upside Ahead
07:25am, Friday, 26'th Jul 2024
2024 has been a great year for U.S. indices, with the benchmark S&P 500 posting new all-time highs 38 times so far. The rally has been primarily driven by the tech sector, focusing on artificial intel
Boston Scientific (BSX) Q2 Earnings Beat, Organic Sales Rise
01:50pm, Wednesday, 24'th Jul 2024
Boston Scientific (BSX) registers a strong year-over-year improvement in sales, indicating solid market share gains in legacy businesses across all geographic regions.
Boston Scientific Profit and Sales Are Boosted by Cardiovascular Device Demand
12:41pm, Wednesday, 24'th Jul 2024
Boston Scientific (BSX) posted an increase in second-quarter earnings and sales on the back of growing demand for its heart devices.
Boston Scientific Corporation (BSX) Q2 2024 Earnings Call Transcript
10:57am, Wednesday, 24'th Jul 2024
Boston Scientific Corporation (NYSE:BSX ) Q2 2024 Earnings Conference Call July 24, 2024 8:00 AM ET Company Participants Jon Monson - SVP, IR Michael F. Mahoney - Chairman and CEO Daniel J.
Boston Scientific (BSX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
10:35am, Wednesday, 24'th Jul 2024
While the top- and bottom-line numbers for Boston Scientific (BSX) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics c
Boston Scientific (BSX) Surpasses Q2 Earnings and Revenue Estimates
08:40am, Wednesday, 24'th Jul 2024
Boston Scientific (BSX) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.53 per share a year ago.
Boston Scientific raises annual profit forecast on heart devices demand
06:37am, Wednesday, 24'th Jul 2024
Boston Scientific raised its full-year profit forecast on Wednesday on the back of strong demand for its heart devices, sending the medical device maker's shares up 2% in premarket trading.
Can These 4 MedTech Stocks Hit Targets This Earnings Season?
01:05pm, Tuesday, 23'rd Jul 2024
Here is a sneak peek into how four MedTech bigshots, BSX, TMO, ALGN and EW, are expected to fare in their second-quarter results, slated to be released tomorrow.
Watchman In Focus As Boston Scientific Reports Its Q2
12:45pm, Tuesday, 23'rd Jul 2024
Boston Scientific (NYSE: BSX) is scheduled to report its Q2 2024 results on Wednesday, July 24. We expect the company to report revenues and earnings in line with the consensus estimates.
HAE vs. BSX: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 23'rd Jul 2024
Investors looking for stocks in the Medical - Products sector might want to consider either Haemonetics (HAE) or Boston Scientific (BSX). But which of these two stocks offers value investors a better
HAE or BSX: Which Is the Better Value Stock Right Now?
12:46pm, Monday, 22'nd Jul 2024
Investors interested in Medical - Products stocks are likely familiar with Haemonetics (HAE) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportu
Boston Scientific (BSX) Banks on Global Expansion, Innovation
12:42pm, Monday, 22'nd Jul 2024
In EMEA, Boston Scientific (BSX) is successfully expanding its base, banking on its diverse portfolio, new launches and commercial execution with healthy underlying market demand.
7 Robotics Stocks That Could Grow Your Wealth
11:00am, Monday, 22'nd Jul 2024
Robotics stocks are a good investment as the industry is rapidly progressing. Robotics stocks have great potential to increase their revenues in the future due to the increased usage of robots in di
Boston Scientific Q2 Earnings Preview: Can The Rally Continue?
02:40pm, Wednesday, 17'th Jul 2024
Boston Scientific is set to report Q2 earnings on July 24th. Growth is benefiting from the launch of recent FDA-approved medtech products. We highlight the themes to watch into the second half of the
Sign In
Buy BSX